生物医药系列产品
数据
资源
版本对比
免费注册
预约演示
免费注册
Children's
Cancer
Research Fund awards $10.5M to
Dana-Farber Cancer Institute
Cancer
Institute, 11 other research organizations
2021-03-17
·
Beckers Hospital Review
Children's
Cancer
Research Fund awards $10.5M to
Dana-Farber Cancer Institute
Cancer
Institute, 11 other research organizations The Children's
Cancer
Research Fund granted $10.5 million to support 12 U.S. research organizations focused on improving treatment and outcomes for childhood cancer patients, the organization said March 16. Developing new pediatric cancer therapies for some of the most difficult to treat
cancers
, including
acute myeloid leukemia
,
sarcomas
and
relapsed liver cancer
, are the key focus areas of the supported research. Researchers at the following healthcare organizations received support: Ann and Robert H. Lurie
Children
's Hospital in Chicago Childhood Cancer &
Leukemia
International Consortium
Children's Cancer Therapy Development Institute
Cancer
Therapy Development Institute in Beaverton, Ore. Children's Hospitals and Clinics of Minnesota in Minneapolis
Children
's Hospital of Philadelphia Children's Oncology Group
Dana-Farber Cancer Institute
Cancer
Institute in Boston
Johns Hopkins University
in Baltimore St.
Jude Children's Research
Hospital in Memphis, Tenn.
University of California San Francisco
University of Chicago
University of Minnesota
Masonic
Cancer
Center in Minneapolis More articles on oncology: New program at Henry Ford
Cancer
Institute will increase minority representation in clinical trials Most US
cancer
centers recommend screening for
breast cancer
earlier than national guidelines St. Baldrick's awards $573K to 3 early-career pediatric oncologists © Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
机构
Children'S Cancer Research Institute
The Johns Hopkins University
The University of California, San Francisco
[+5]
适应症
癌症
急性髓性白血病
肉瘤
[+3]
靶点
-
药物
-
标准版
¥
16800
元/账号/年
新药情报库 | 省钱又好用!
立即使用
来和芽仔聊天吧
热门报告
特应性皮炎深度解析:药物开发、专利分析与风险评估
智慧芽生物医药
2024年7月全球首批及特殊审评药物报告
智慧芽生物医药
GPRC5D靶点专利调研报告
智慧芽生物医药
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
开始免费试用
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。
试用数据服务